Serina Therapeutics, Inc. ($SER)
Filing Information
| Accession Number | 0001413350-26-000004 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 22, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
336,516
Total Value
$722,571.67
P&L
+2755.3% (+$28,887.29)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | May 22, 2026 | Purchase | 589 | $1.78 | $1,048.42 | 589 | Direct | โ | View Details | |
Director | Common Stock | โ | Jun 17, 2026 | Conversion | 224,152 | $2.25 | $504,342.00 | 231,705 | Indirect | The Jay Venkatesan Legacy Trust | View Details | |
Director | Stock Option (right to buy) | Derivative | Jun 17, 2026 | Grant/Award | 15,250 | $0.00 | $0.00 | 15,250 | Direct | โ | View Details | |
Director | Series A Convertible Preferred Stock | Derivative | Jun 17, 2026 | Conversion | 96,525 | $2.25 | $217,181.25 | 0 | Indirect | The Jay Venkatesan Legacy Trust | View Details |